Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

Clinical trial NCT07397611 · RECRUITING

Trial details

NCT number: NCT07397611
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Kidney Cancer Kidney Neoplasm Renal Carcinoma

Start date: 2026-03-09
Primary completion: 2028-01-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.